Drug name - Aggrastat

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6770660 MEDICURE Method for inhibiting platelet aggregation May, 2023

(6 months from now)

Drugs and Companies using TIROFIBAN HYDROCHLORIDE ingredient

Treatment: A dosing regimen of aggrastat (tirofiban hydrochloride)(25mcg/kg followed by 0.15mcg/kg/min infusion) to reduce the rate of thrombotic coronary events associated with acute coronary syndrome (acs) in patients with non-st elevation acs

Dosage: INJECTABLE;INJECTION; SOLUTION;INJECTION

More Information on Dosage
Strength Dosage Availability
EQ 12.5MG BASE/50ML (EQ 0.25MG BASE/ML) INJECTABLE;INJECTION Discontinued
EQ 3.75MG BASE/15ML (EQ 0.25MG BASE/ML) SOLUTION;INJECTION Prescription

availability in other generic markets.

Click on the highlighted region to filter.